Phathom Pharmaceuticals Inc. (PHAT)
Market Open
12 Jun, 15:26
NASDAQ (NGS) NASDAQ (NGS) Primary $
10. 58
+0.31
+3.0185%
$
786.39M Market Cap
- P/E Ratio
- Div Yield
120,251 Volume
-4.59 Eps
$ 10.27
Previous Close Want to track PHAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
PHAT Earnings Reports FAQ
What is the earnings per share (EPS) for PHAT?
The current EPS is -4.59.
What is the company's earnings growth rate?
Phathom Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Phathom Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Phathom Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for PHAT at this time, as Phathom Pharmaceuticals Inc has no recent EPS data to calculate it.
